YM-750 is primarily utilized in the field of medical research, particularly in studies related to cardiovascular diseases. It has been investigated for its potential to inhibit platelet aggregation, which makes it a candidate for the development of antithrombotic agents. Researchers have explored its efficacy in preventing blood clots, which could be beneficial in treating conditions like myocardial infarction and stroke. Additionally, YM-750 has been studied for its role in improving endothelial function, which is crucial for maintaining vascular health. Its application in preclinical trials has shown promise in reducing the risk of thrombotic events, making it a subject of interest for further pharmaceutical development.